Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02441517
Title A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel Treatment in Patients Who Have Previously Received Enzalutamide
Recruitment Terminated
Gender male
Phase FDA approved
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Site US10003 Evanston Illinois 60201 United States Details
Site US10006 Worcester Massachusetts 01605 United States Details
Site US10004 New York New York 10029 United States Details
Site US10001 Charleston South Carolina 29425 United States Details
Site US10002 Myrtle Beach South Carolina 29572 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field